Relationship between the coronavirus epidemic and the use of complementary and alternative medicine prior to elective

Sándor Árpád Soós1,2, Orsolya Szűcs1, Katalin Darvas1,3

  • 11 Semmelweis Egyetem, Általános Orvostudományi Kar, I. Sz. Sebészeti és Intervenciós Gasztroenterológiai Klinika, Budapest, Üllői út 78., 1082.

Orvosi Hetilap
|October 17, 2021
PubMed

Insights

The COVID-19 pandemic did not significantly alter most patients' views on complementary therapies, though some became more optimistic. Only 10% of patients used alternative medicine to prevent coronavirus infection.

Area of Science:

  • Medical research
  • Public health

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, significantly impacted global health and daily life.
  • The absence of specific therapies led some individuals to explore alternative treatments.

Purpose of the Study:

  • To investigate the influence of the COVID-19 pandemic on patients' attitudes towards complementary and alternative medicine (CAM).
  • To assess the utilization of CAM, including herbal preparations, among patients awaiting elective surgery during the pandemic.

Main Methods:

  • An anonymous questionnaire survey was conducted among patients awaiting elective surgery in Hungary.
  • Data were collected between August 3 and December 18, 2020, with 279 valid responses (69.7% response rate).

Main Results:

  • Over 91% of respondents maintained their pre-pandemic views on CAM; 8.2% viewed it more favorably.
  • Only 10% of patients used CAM for coronavirus infection prevention, and no one initiated CAM solely due to the pandemic.
  • Herbal preparation use was reported by 27.5% during the epidemic, with no significant socio-demographic correlations found.

Conclusions:

  • The COVID-19 pandemic likely led to a decrease in overall CAM use due to restrictions, but herbal remedy usage remained relatively stable.
  • Approximately one-tenth of surveyed patients utilized CAM for preventing coronavirus infection.
  • CAM use was notably lower among cancer and thromboembolic patients.

Related Concept Videos